Medical device co Nyxoah plunges on stock offering
BUZZ-Medical device co Nyxoah plunges on stock offering ** U.S.-listed shares of Belgian medical device maker Nyxoah SA NYXH.O plunge 50% to record low $1.44 early Fri as it looks to raise equity
** Co focused on obstructive sleep apnea solutions late Thurs commenced stock offering
** It intends to use net offering proceeds to expand commercialization activities for its Genio system in the U.S., finance R&D and advance commercialization of the system outside of the U.S., among other purposes
** BofA lead bookrunner, joined by Bank Degroof Petercam
** Co had ~43.66 mln shares outstanding as of Mar 31, per the prospectus
** Through Thurs close, NYXH shares had shed 37% YTD
(Lance Tupper is a Reuters market analyst. The views expressed are his own)
((lance.tupper@tr.com 1-646-279-6380))
Recent news on Nyxoah SA
See all newsBelgium's Nyxoah Q3 revenue rises on US commercialization
Brief: Nyxoah SA Q3 Gross Profit EUR 5.785 Million
Brief: Nyxoah SA Submits Pma Supplement To FDA To Expand Genio Indication To Complete Concentric Collapse Patients
Brief: Nyxoah Says Co Appoints Liam Kelly As Chief Executive Officer Effective October 1
Brief: Cvrx Appoints John Landry As Chief Financial Officer